Search
Showing results for "A"
News & Events
Technology proves a gamechangerHeidi Bucktin likes to think of her family’s life as pre and post continuous glucose monitoring – that’s how markedly different the two periods are in their journey of living with a child with type 1 diabetes.
Research
Progress toward a global group a streptococcal vaccineThe desire for an effective vaccine arises from the large burden of disease caused by the bacterium, particularly rheumatic fever and rheumatic heart disease.
Research
Group A streptococcal vaccines: Paving a path for accelerated developmentVaccine prevention of GAS infections and their immunological complications has been a goal of researchers for decades.
The Strep A & ARF Therapeutics research team are working to accelerate research and clinical trials to improve penicillin formulation and treatment methods, to end RHD.
News & Events
Moira takes on a mountain in a crusade for a cureOn July 8, Professor Moira Clay will fly out to France and Italy as part of The Telethon Adventurers challenge to raise critical funds to assist researchers
Research
Strabismus, a preventable barrier to social participation: A short reportIsolated strabismus does not significantly impair visual functionality and has traditionally been considered a primarily cosmetic defect of little importance.
News & Events
World Breastfeeding Week: Q&AIn celebration of World Breastfeeding Week (1 – 7 August), we sat down with Professor Valerie Verhasselt to ask her some of the top questions about breastfeeding and immunology.
News & Events
Aveni awarded a JDRF fellowshipCongratulations to Children’s Diabetes Centre’s Dr Aveni Haynes on being awarded a JDRF Postdoctoral Fellowship to inform type 1 diabetes prevention strategies by investigating early blood glucose abnormalities in at-risk children.
Research
Breastfeeding in a COVID-19 worldThe coronavirus disease 2019 (COVID-19) pandemic has changed the birthing and postnatal experience of women. This review highlights how policy changes have affected pregnant and breastfeeding women, the evidence for continued breastfeeding and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, and how the pandemic's unexpected consequences have affected these women's wellbeing.
Research
Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigationOn 8th April 2021, the Australian Technical Advisory Group on Immunisation (ATAGI) made the Pfizer-BioNtech (Comirnaty) vaccine the “preferred” vaccine for adults in Australia aged < 50 years due to a risk of thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca vaccination. We sought to understand whether this impacted COVID-19 vaccine intentions.